Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-12-05

Clinical Trial Update: Effect of Levodopa on Cardiovascular Autonomic Function in Parkinson's Disease [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial assessed the effect of levodopa on cardiovascular autonomic function in Parkinson disease, including patients with orthostatic hypote…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • levodopa (levodopa)

Snippet

Sponsor: University of Utah | Conditions: Parkinson Disease, Orthostatic Hypotension | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2024-12-05